← All companies

Dyne Therapeutics

Healthcare & Life Sci

Company overview

Dyne Therapeutics is a biotechnology company. It develops nucleic acid therapies for rare neuromuscular diseases. Its pipeline includes zeleciment rostudirsen (DYNE-251) for Duchenne muscular dystrophy, zeleciment basivarsen (DYNE-101) for myotonic dystrophy type 1, and DYNE-302 for facioscapulohumeral muscular dystrophy. The company is based in Waltham, Massachusetts.

Dyne Therapeutics trades on the Nasdaq stock exchange. That matters: as a public company, it must share its finances and drug trial results with regulators, so people can follow its progress. Dyne Therapeutics is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
Waltham, United States

Filters

Create your account

Create an account to save jobs and track applications.